Citadel Advisors
AGN

Citadel Advisors’s Allergan plc AGN Stock Holding History

Citadel Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-59,100
Closed -$10.5M – 10920
2020
Q1 		$10.5M Sell
59,100
-175,500
-75% -$33M ﹤0.01% 1801
2019
Q4 		$44.8M Sell
234,600
-110,500
-32% -$19.9M 0.02% 838
2019
Q3 		$58.1M Sell
345,100
-160,800
-32% -$26.2M 0.03% 673
2019
Q2 		$84.7M Buy
505,900
+74,000
+17% +$10.2M 0.04% 468
2019
Q1 		$63.2M Sell
431,900
-200,100
-32% -$29M 0.03% 580
2018
Q4 		$84.5M Buy
632,000
+7,800
+1% +$1.28M 0.05% 382
2018
Q3 		$119M Buy
624,200
+175,500
+39% +$32.2M 0.05% 352
2018
Q2 		$74.8M Sell
448,700
-141,900
-24% -$22.8M 0.04% 493
2018
Q1 		$99.4M Buy
590,600
+42,500
+8% +$7.13M 0.05% 326
2017
Q4 		$89.7M Buy
548,100
+90,300
+20% +$16.2M 0.05% 367
2017
Q3 		$93.8M Sell
457,800
-8,700
-2% -$2.02M 0.07% 279
2017
Q2 		$113M Sell
466,500
-82,300
-15% -$19.3M 0.1% 190
2017
Q1 		$131M Sell
548,800
-136,000
-20% -$31.7M 0.12% 138
2016
Q4 		$144M Buy
684,800
+66,700
+11% +$13.8M 0.15% 105
2016
Q3 		$142M Buy
618,100
+88,800
+17% +$21.7M 0.14% 96
2016
Q2 		$122M Buy
529,300
+205,200
+63% +$47.3M 0.14% 109
2016
Q1 		$86.9M Sell
324,100
-10,000
-3% -$2.86M 0.11% 153
2015
Q4 		$104M Buy
334,100
+17,300
+5% +$5.15M 0.11% 185
2015
Q3 		$86.1M Buy
316,800
+111,100
+54% +$34.1M 0.08% 238
2015
Q2 		$62.4M Sell
205,700
-28,100
-12% -$8.38M 0.05% 407
2015
Q1 		$69.6M Buy
233,800
+7,500
+3% +$2.14M 0.07% 346
2014
Q4 		$58.3M Buy
226,300
+30,200
+15% +$7.55M 0.06% 396
2014
Q3 		$47.3M Buy
196,100
+66,100
+51% +$14.8M 0.05% 441
2014
Q2 		$29M Sell
130,000
-61,600
-32% -$12.8M 0.03% 624
2014
Q1 		$39.4M Buy
191,600
+104,100
+119% +$20.6M 0.05% 492
2013
Q4 		$14.7M Sell
87,500
-65,500
-43% -$10.2M 0.02% 976
2013
Q3 		$22M Buy
153,000
+65,400
+75% +$8.71M 0.03% 677
2013
Q2 		$11.1M Buy
+87,600
New +$9.92M 0.02% 1005

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citadel Advisors's AGN Position: Q2 2020 in Review

Citadel Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,402,442 shares — an estimated $603M sold.

Citadel Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $603M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citadel Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citadel Advisors sold 3,402,442 Allergan plc shares in Q2 2020, an estimated $603M.
  • Citadel Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Citadel Advisors's Allergan plc position peaked at $603M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.